These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 1673686

  • 1. Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking.
    Suda K, Smith DM, Ghatei MA, Murphy JK, Bloom SR.
    J Clin Endocrinol Metab; 1991 May; 72(5):958-64. PubMed ID: 1673686
    [Abstract] [Full Text] [Related]

  • 2. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
    Gottschall PE, Tatsuno I, Miyata A, Arimura A.
    Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
    [Abstract] [Full Text] [Related]

  • 3. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ.
    J Mol Neurosci; 2005 Jul; 25(3):215-24. PubMed ID: 15800375
    [Abstract] [Full Text] [Related]

  • 4. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC.
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [Abstract] [Full Text] [Related]

  • 5. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML, Modesti A, Palumbo C, Ulisse S, Fabbri A, Piccione E, Frajese G, Moretti C.
    Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
    [Abstract] [Full Text] [Related]

  • 6. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 7. Receptors for pituitary adenylate cyclase-activating peptide in human liver.
    Guijarro LG, Rodriguez-Henche N, García-López E, Noguerales F, Dapena MA, Juarranz MG, Prieto JC.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2451-7. PubMed ID: 7629241
    [Abstract] [Full Text] [Related]

  • 8. Investigation of the interaction of VIP binding sites with VIP and PACAP in human brain.
    Suda K, Smith DM, Ghatei MA, Bloom SR.
    Neurosci Lett; 1992 Mar 16; 137(1):19-23. PubMed ID: 1320752
    [Abstract] [Full Text] [Related]

  • 9. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    J Mol Neurosci; 2003 Apr 16; 20(2):153-62. PubMed ID: 12794309
    [Abstract] [Full Text] [Related]

  • 10. Hypothalamic binding sites for pituitary adenylate cyclase activating polypeptide: characterization and molecular identification.
    Gottschall PE, Tatsuno I, Arimura A.
    FASEB J; 1991 Feb 16; 5(2):194-9. PubMed ID: 1848519
    [Abstract] [Full Text] [Related]

  • 11. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions.
    Shivers BD, Görcs TJ, Gottschall PE, Arimura A.
    Endocrinology; 1991 Jun 16; 128(6):3055-65. PubMed ID: 2036976
    [Abstract] [Full Text] [Related]

  • 12. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO, Leung MY, Shea WL, Tse LY, Chang JP, Chow BK.
    Endocrinology; 1998 Aug 16; 139(8):3465-79. PubMed ID: 9681497
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.
    Tatsuno I, Gottschall PE, Arimura A.
    Endocrinology; 1991 Feb 16; 128(2):728-34. PubMed ID: 1989859
    [Abstract] [Full Text] [Related]

  • 14. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages.
    Pozo D, Delgado M, Martinez C, Gomariz RP, Guerrero JM, Calvo JR.
    Biochim Biophys Acta; 1997 Dec 12; 1359(3):250-62. PubMed ID: 9434131
    [Abstract] [Full Text] [Related]

  • 15. PAC1 receptors in chick cerebral cortex: characterization by binding of pituitary adenylate cyclase-activating polypeptide, [125I]-PACAP27.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Neurosci Lett; 2003 Feb 27; 338(2):155-8. PubMed ID: 12566176
    [Abstract] [Full Text] [Related]

  • 16. Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity.
    Margiotta JF, Pardi D.
    Mol Pharmacol; 1995 Jul 27; 48(1):63-71. PubMed ID: 7623776
    [Abstract] [Full Text] [Related]

  • 17. Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
    Robberecht P, Gourlet P, De Neef P, Woussen-Colle MC, Vandermeers-Piret MC, Vandermeers A, Christophe J.
    Mol Pharmacol; 1992 Aug 27; 42(2):347-55. PubMed ID: 1325033
    [Abstract] [Full Text] [Related]

  • 18. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain.
    Schäfer H, Schwarzhoff R, Creutzfeldt W, Schmidt WE.
    Eur J Biochem; 1991 Dec 18; 202(3):951-8. PubMed ID: 1662620
    [Abstract] [Full Text] [Related]

  • 19. Recognition of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide (PACAP/VIP) hybrids and related peptides by rat brain membranes.
    Ando E, Nokihara K, Naruse S, Wray V.
    Biomed Pept Proteins Nucleic Acids; 1996 Dec 18; 2(2):41-6. PubMed ID: 9346825
    [Abstract] [Full Text] [Related]

  • 20. Binding sites of a novel neuropeptide pituitary-adenylate-cyclase-activating polypeptide in the rat brain and lung.
    Lam HC, Takahashi K, Ghatei MA, Kanse SM, Polak JM, Bloom SR.
    Eur J Biochem; 1990 Nov 13; 193(3):725-9. PubMed ID: 2249690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.